Annual ROA
-75.81%
-23.27%-44.29%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual return on assets is -75.81%, with the most recent change of -23.27% (-44.29%) on December 1, 2023.
- During the last 3 years, NBY annual ROA has risen by +7.64% (+9.16%).
- NBY annual ROA is now -542.56% below its all-time high of 17.13%, reached on December 31, 2009.
Performance
NBY ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROA
-144.37%
-31.35%-27.74%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly return on assets is -144.37%, with the most recent change of -31.35% (-27.74%) on September 1, 2024.
- Over the past year, NBY quarterly ROA has dropped by -61.07% (-73.31%).
- NBY quarterly ROA is now -899.83% below its all-time high of 18.05%, reached on December 31, 2009.
Performance
NBY Quarterly ROA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROA Formula
ROA = Net Income
Total Assets ✕ 100%
Total Assets ✕ 100%
NBY ROA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -44.3% | -73.3% |
| 3 y3 years | +9.2% | -117.2% |
| 5 y5 years | -12.6% | -117.2% |
NBY ROA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -155.3% | at low | -1083.4% | at low |
| 5 y | 5-year | -155.3% | +19.2% | -1083.4% | at low |
| alltime | all time | -542.6% | +74.8% | -899.8% | +47.9% |
NovaBay Pharmaceuticals ROA History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -144.37%(+27.7%) |
| Jun 2024 | - | -113.02%(+18.1%) |
| Mar 2024 | - | -95.69%(+37.2%) |
| Dec 2023 | -75.81%(+44.3%) | -69.74%(-16.3%) |
| Sep 2023 | - | -83.30%(+25.3%) |
| Jun 2023 | - | -66.47%(+8.6%) |
| Mar 2023 | - | -61.22%(+25.9%) |
| Dec 2022 | -52.54%(+76.9%) | -48.62%(+298.5%) |
| Sep 2022 | - | -12.20%(-50.2%) |
| Jun 2022 | - | -24.51%(-1.6%) |
| Mar 2022 | - | -24.90%(-32.3%) |
| Dec 2021 | -29.70%(-64.4%) | -36.80%(-28.3%) |
| Sep 2021 | - | -51.36%(-9.9%) |
| Jun 2021 | - | -57.00%(-28.2%) |
| Mar 2021 | - | -79.37%(-4.7%) |
| Dec 2020 | -83.45%(-11.1%) | -83.27%(-8.7%) |
| Sep 2020 | - | -91.17%(+18.0%) |
| Jun 2020 | - | -77.28%(+20.3%) |
| Mar 2020 | - | -64.23%(-27.1%) |
| Dec 2019 | -93.85%(+39.4%) | -88.16%(+15.4%) |
| Sep 2019 | - | -76.41%(-17.9%) |
| Jun 2019 | - | -93.06%(+19.2%) |
| Mar 2019 | - | -78.07%(+32.0%) |
| Dec 2018 | -67.34%(+15.8%) | -59.14%(+50.4%) |
| Sep 2018 | - | -39.31%(-14.4%) |
| Jun 2018 | - | -45.91%(-1.1%) |
| Mar 2018 | - | -46.41%(-23.2%) |
| Dec 2017 | -58.15%(-54.8%) | -60.41%(-18.6%) |
| Sep 2017 | - | -74.20%(-17.0%) |
| Jun 2017 | - | -89.38%(-18.4%) |
| Mar 2017 | - | -109.58%(-20.8%) |
| Dec 2016 | -128.57%(-57.3%) | -138.33%(-31.6%) |
| Sep 2016 | - | -202.18%(-20.4%) |
| Jun 2016 | - | -254.05%(-8.3%) |
| Mar 2016 | - | -277.07%(+9.9%) |
| Dec 2015 | -300.82% | -252.08%(+14.3%) |
| Sep 2015 | - | -220.61%(+22.1%) |
| Jun 2015 | - | -180.62%(+27.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | -141.63%(+21.0%) |
| Dec 2014 | -131.06%(+42.5%) | -117.01%(+9.6%) |
| Sep 2014 | - | -106.72%(+5.2%) |
| Jun 2014 | - | -101.46%(-4.6%) |
| Mar 2014 | - | -106.37%(-0.0%) |
| Dec 2013 | -91.97%(+130.3%) | -106.42%(+9.6%) |
| Sep 2013 | - | -97.11%(+37.7%) |
| Jun 2013 | - | -70.52%(+23.4%) |
| Mar 2013 | - | -57.13%(+21.9%) |
| Dec 2012 | -39.93%(+23.6%) | -46.86%(-16.4%) |
| Sep 2012 | - | -56.08%(+2.2%) |
| Jun 2012 | - | -54.89%(+52.2%) |
| Mar 2012 | - | -36.07%(+12.8%) |
| Dec 2011 | -32.31%(+23.9%) | -31.99%(+278.1%) |
| Sep 2011 | - | -8.46%(-60.0%) |
| Jun 2011 | - | -21.14%(-33.8%) |
| Mar 2011 | - | -31.91%(+12.6%) |
| Dec 2010 | -26.08%(-252.2%) | -28.35%(+307.3%) |
| Sep 2010 | - | -6.96%(-321.0%) |
| Jun 2010 | - | 3.15%(-65.0%) |
| Mar 2010 | - | 9.01%(-50.1%) |
| Dec 2009 | 17.13%(-140.0%) | 18.05%(-219.5%) |
| Sep 2009 | - | -15.10%(-34.7%) |
| Jun 2009 | - | -23.13%(-29.4%) |
| Mar 2009 | - | -32.78%(-21.8%) |
| Dec 2008 | -42.83%(+41.9%) | -41.94%(-4.3%) |
| Sep 2008 | - | -43.84%(-9.7%) |
| Jun 2008 | - | -48.54%(+1.5%) |
| Mar 2008 | - | -47.80%(+14.6%) |
| Dec 2007 | -30.18%(-32.3%) | -41.70%(-18.3%) |
| Sep 2007 | - | -51.02%(+10.6%) |
| Jun 2007 | - | -46.14%(+8.6%) |
| Mar 2007 | - | -42.49%(-4.6%) |
| Dec 2006 | -44.55%(-54.2%) | -44.55%(-67.9%) |
| Sep 2006 | - | -138.99%(+11.4%) |
| Jun 2006 | - | -124.73%(+16.4%) |
| Mar 2006 | - | -107.13%(+10.2%) |
| Dec 2005 | -97.22%(+30.8%) | -97.25% |
| Dec 2003 | -74.30% | - |
FAQ
- What is NovaBay Pharmaceuticals annual return on assets?
- What is the all time high annual ROA for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual ROA year-on-year change?
- What is NovaBay Pharmaceuticals quarterly return on assets?
- What is the all time high quarterly ROA for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly ROA year-on-year change?
What is NovaBay Pharmaceuticals annual return on assets?
The current annual ROA of NBY is -75.81%
What is the all time high annual ROA for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual return on assets is 17.13%
What is NovaBay Pharmaceuticals annual ROA year-on-year change?
Over the past year, NBY annual return on assets has changed by -23.27% (-44.29%)
What is NovaBay Pharmaceuticals quarterly return on assets?
The current quarterly ROA of NBY is -144.37%
What is the all time high quarterly ROA for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly return on assets is 18.05%
What is NovaBay Pharmaceuticals quarterly ROA year-on-year change?
Over the past year, NBY quarterly return on assets has changed by -61.07% (-73.31%)